Printer Friendly

QUEST MEDICAL, INC. (NASDAQ) ACQUIRES 'ACTESTER' PRODUCT LINE FROM MCGAW INC.

 QUEST MEDICAL, INC. (NASDAQ) ACQUIRES
 'ACTESTER' PRODUCT LINE FROM MCGAW INC.
 DALLAS, June 18 /PRNewswire/ -- QUEST MEDICAL INC. (NASDAQ: QMED), a manufacturer of proprietary disposable products for the health care industry, announced at today's annual meeting that it has an agreement to acquire from McGaw Inc. the assets related to McGaw's "ACTester" product line for $500,000 cash. The transaction is scheduled to close on Friday, June 19, 1992.
 The ACTester product line consists of instrumentation and disposables used to measure the activated clotting time (ACT) of blood, a key parameter in managing patient coagulation status in applications such as dialysis, open heart surgery, cardiac catheterization, ECMO, and other critical care applications.
 ACTester sales were $435,000 for 1991 and $210,000 for the first four months of 1992 ended April 30. Explaining that Quest plans to consolidate the product line into its Dallas operations, president Thomas C. Thompson said, "We expect ACTesters to begin contributing to earnings immediately."
 Thompson added, "ACTester sales historically have emphasized the dialysis market, but we believe the technology can be adapted for cardiovascular applications, complementing Quest's strategic focus on the cardiovascular market."
 -0- 6/18/92
 /CONTACT: F. Robert Merrill III, Vice President/Finance of Quest Medical, 214-387-2740/
 (QMED) CO: Quest Medical Inc.; McGaw Inc. ST: Texas IN: MTC SU: TNM PDT


CH -- LA007 -- 1432 06/18/92 10:42 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 18, 1992
Words:227
Previous Article:ELAN'S LONG-ACTING DILTIAZEM APPROVED IN EIGHT EUROPEAN COUNTRIES
Next Article:FIRST PEOPLES DECLARES REGULAR DIVIDEND ON COMMON STOCK
Topics:


Related Articles
QUEST MEDICAL INC. PRE-TAX OPERATING EARNINGS RISE TO $424,000 FOR THE FOURTH QUARTER FROM $17,000 LAST YEAR AS REVENUE INCREASES 81 PERCENT
QUEST MEDICAL, INC. (NASDAQ) SECOND QUARTER OPERATING EARNINGS ADVANCE 78 PERCENT ON 43 PERCENT REVENUE GAIN
QUEST MEDICAL INC. REPORTS FOURTH QUARTER, 1992 RESULTS
McGAW INC. REPORTS RECORD SECOND QUARTER REVENUES
QUEST MEDICAL INC. (NASDAQ) BOARD AUTHORIZES REPURCHASE OF UP TO 390,000 SHARES
IVAX TO ACQUIRE MCGAW
IVAX CORPORATION AND MCGAW COMPLETE PREVIOUSLY ANNOUNCED TRANSACTION
QUEST MEDICAL COMPLETES ACQUISITION OF NEUROMED, INC.
QUEST MEDICAL EXPECTS PROMPT REVIEW AND CLEARANCE OF MPS FROM FDA
QUEST MEDICAL RELEASES MPS' MYOCARDIAL PROTECTION SYSTEM TO MARKET

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters